Generic, Branded Generic and Proprietary Medicinal Products — Group 8 [3111381]
A Contract Award Notice
by BUSINESS SERVICES ORGANISATION, PROCUREMENT & LOGISTICS SERVICE
- Source
- OJEU
- Type
- Contract (Supply)
- Duration
- 5 year (est.)
- Value
- £6M
- Sector
- HEALTH
- Published
- 28 Sep 2021
- Delivery
- To 14 Dec 2030 (est.)
- Deadline
- n/a
Concepts
Location
Belfast
2 buyers
27 suppliers
- Abbvie Maidenhead
- Alliance Pharmaceuticals Chippenham
- Astellas Pharma Woking
- Baxter Healthcare Thetford
- Chiesi Manchester
- Desitin Pharma Woking
- Focus Pharmaceuticals London
- Fresenius Kabi Runcorn
- Glaxosmithkline Brentford
- Hameln Pharma Gloucester
- Intrapharm Laboratories Maidenhead
- Janssen Cilag High Wycombe
- Kent Pharma Heathrow
- Kyowa Kirin Galashiels
- Martindale Pharma Romford
- Morningside Pharmaceuticals Loughborough
- Mylan Hatfield
- Norgine Pharmaceuticals Uxbridge
- Novartis Pharmaceuticals London
- Pfizer Sandwich
- Ranbaxy Hayes
- Teva Castleford
- Torbay Pharmaceuticals Paignton
- Typharm Norwich
- Ucb Pharma Slough
- Wockhardt Wrexham
- Zentiva London
Description
Generic, Branded Generic and Proprietary Medicinal Products — Group 8 [3111381]
Total Quantity or Scope
Generic, Branded Generic and Proprietary Medicinal Products — Group 8 [3111381] is established under the Medicinal Products Dynamic Purchasing System [131864]. The contract is awarded on behalf of the following contract participants: (i) Belfast Health and Social Care Trust (BHSCT); (ii) South Eastern Health and Social Care Trust (SEHSCT); (iii) Northern Health and Social Care Trust (NHSCT); (iv) Southern Health and Social Care Trust (SHSCT); (v) Western Health and Social Care Trust (WHSCT); (vi) Northern Ireland Ambulance Service (NIAS); (vii) Northern Ireland Blood Transfusion Service (NIBTS); (viii) Business Services Organisation (BSO); (ix) Public Health Agency (PHA); (x) Department of Health, Northern Ireland (DoH(NI)); (xi) Health and Social Care Board (HSCB).
Award Detail
1 | Abbvie (Maidenhead)
|
2 | Alliance Pharmaceuticals (Chippenham)
|
3 | Astellas Pharma (Woking)
|
4 | Baxter Healthcare (Thetford)
|
5 | Chiesi (Manchester)
|
6 | Desitin Pharma (Woking)
|
7 | Focus Pharmaceuticals (London)
|
8 | Fresenius Kabi (Runcorn)
|
9 | Glaxosmithkline (Brentford)
|
10 | Hameln Pharma (Gloucester)
|
11 | Intrapharm Laboratories (Maidenhead)
|
12 | Janssen Cilag (High Wycombe)
|
13 | Kent Pharma (Heathrow)
|
14 | Kyowa Kirin (Galashiels)
|
15 | Martindale Pharma (Romford)
|
16 | Morningside Pharmaceuticals (Loughborough)
|
17 | Mylan (Hatfield)
|
18 | Norgine Pharmaceuticals (Uxbridge)
|
19 | Novartis Pharmaceuticals (London)
|
20 | Pfizer (Sandwich)
|
21 | Ranbaxy (Hayes)
|
22 | Teva (Castleford)
|
23 | Torbay Pharmaceuticals (Paignton)
|
24 | Typharm (Norwich)
|
25 | Ucb Pharma (Slough)
|
26 | Wockhardt (Wrexham)
|
27 | Zentiva (London)
|
Award Criteria
Compliance with Contract Scope and Specification | _ |
Supply and Delivery of Product: Same Working Day Delivery | 5.0 |
Supply and Delivery of Product: Wholesale Distribution | 5.0 |
Continuity of Supply: Minimum Committed Stockholding | 8.0 |
Governance, Quality Control and Risk: Pharmaceutical Quality Assessment (PQA) Section 1 | _ |
Governance, Quality Control and Risk: Pharmaceutical Quality Assessment (PQA) Section 2 – Section 6 (inclusive) | 40.0 |
PRICE | 42.0 |
CPV Codes
- 33600000 - Pharmaceutical products
Indicators
- Award on basis of price and quality.
Other Information
The estimated total value of contract (excluding VAT) is GBP 5 500 000 to GBP 33 750 000. This estimated total value figure takes into consideration and accounts for all available extension provision as outlined in the SS17bc Commercial Conditions of Contract for Supplies Contracts document and provides for potential growth of up to 50% over the course of the contract. The total value of contract (detailed in section V.2.4)) awarded to each of the contractors indicated in this notice is based on an initial contract period of 24 months. It is important to note that there is available provision to extend this initial contract period in accordance with Section 2 of the SS17bc Commercial Conditions of Contract for Supplies Contracts document.
Reference
- OJEU 490410-2021